<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_40944.rss?id=40944">
    <title>Pharmaceutical Technology - Drug Delivery</title>

    <link>http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Article/list/40944</link>

    <description>Tablets &amp; capsules, liquid-dosage forms. Inhalables &amp; intranasals. Injectables: intravenous,
    intramuscular &amp; subcutaneous. Nanotechnology, dissolvable films and tablets &amp; radio frequency transdermal
    drug delivery.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Fifty-Percent-of-MS-Patients-Avoid-Treatment-Over-/ArticleStandard/Article/detail/642553?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Reducing-Supercooling-during-the-Lyophilization-of/ArticleStandard/Article/detail/634666?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-robust-formoterol-containing-suspension/ArticleStandard/Article/detail/629832?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Encaps-deal-to-target-colonic-drug-delivery/ArticleStandard/Article/detail/624872?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Controlled-Release-Formulations-a-Popular-Strategy/ArticleStandard/Article/detail/624970?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/One-Shot-H1N1-Vaccine-Gets-Chinese-Thumbs-Up/ArticleStandard/Article/detail/623600?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-Incompatibility-probl/ArticleStandard/Article/detail/621300?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets-The-Effect-of-Recent/ArticleStandard/Article/detail/623097?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-unstable-and-unpatent/ArticleStandard/Article/detail/621293?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Researchers-Develop-First-Aptamer-Liposome-Deliver/ArticleStandard/Article/detail/620135?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Topical-Dermatological-Formulation-Development-nda/ArticleStandard/Article/detail/612809?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Advances-in-the-Pharmaceutical-Sciences/ArticleStandard/Article/detail/608519?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/A-Tale-of-Two-Techniques/ArticleStandard/Article/detail/607461?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Novel-Approaches-for-Oral-Insulin-Delivery/ArticleStandard/Article/detail/609407?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Down-the-Track-Different-Speeds-with-Multiple-APIs/ArticleStandard/Article/detail/607448?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Cobras-oral-vaccination-platform/ArticleStandard/Article/detail/597972?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/David-Blakey-151-Accelerating-the-development-proc/ArticleStandard/Article/detail/595120?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/Prefilled-syringes-proving-popular/ArticleStandard/Article/detail/598148?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/New-drug-delivery-device-for-GSKs-iAvamysi/ArticleStandard/Article/detail/597070?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/596054?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/drug+delivery/Narrowing-the-gap-between-clinical-capsule-formula/ArticleStandard/Article/detail/595149?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/drug+delivery/Orally-disintegrating-tablets-the-path-to-improved/ArticleStandard/Article/detail/595066?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/Inhaler-helps-influenza-clinical-trial/ArticleStandard/Article/detail/593885?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Feature+Articles/Influence-of-Superdisintegrants-on-the-Rate-of-Dru/ArticleStandard/Article/detail/590450?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/A-smoother-alternative-to-needles/ArticleStandard/Article/detail/588581?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Latest+News/Patent-secures-new-drug-delivery-method/ArticleStandard/Article/detail/582537?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40944&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40944&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-21T19:47:08Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Fifty-Percent-of-MS-Patients-Avoid-Treatment-Over-/ArticleStandard/Article/detail/642553?contextCategoryId=40944&amp;ref=25">

    <title>Fifty Percent of MS Patients Avoid Treatment Over Injectable Delivery Fears</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Fifty-Percent-of-MS-Patients-Avoid-Treatment-Over-/ArticleStandard/Article/detail/642553?contextCategoryId=40944&amp;ref=25</link>

    <description>Around half of all multiple sclerosis (MS) patients that are eligible for treatment do not receive it
    and one in five of those patients that do begin therapy, delay doing so because of fear and anxiety over the
    treatment process, and not fear and anxiety about the disease.</description>

    <dc:date>2009-11-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642553null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40944&amp;ref=25">

    <title>Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete
    response letter; Watson appoints VP of global operations; more...</description>

    <dc:date>2009-11-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40944&amp;ref=25">

    <title>Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO;
    More...</description>

    <dc:date>2009-11-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40944&amp;ref=25">

    <title>AAPS Announces Annual Awards, Names 2009 Fellows</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40944&amp;ref=25</link>

    <description>The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the
    organization's 2009 Annual Meeting and Exposition in Los Angeles this week.</description>

    <dc:date>2009-11-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40944&amp;ref=25">

    <title>Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson &amp;amp;amp; Johnson Announces Restructuring;
    PPD Acquires Chinese CRO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its
    business team.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40944&amp;ref=25">

    <title>Stay Afloat with Lessons Learned</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40944&amp;ref=25</link>

    <description>FDA's Edwin Rivera-Martinez on dodging supply-chain challenges.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40944&amp;ref=25">

    <title>DIY Healthcare Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40944&amp;ref=25</link>

    <description>While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the
    game too.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?contextCategoryId=40944&amp;ref=25">

    <title>Technology Forecast for Injectables</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?contextCategoryId=40944&amp;ref=25</link>

    <description>A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive
    material.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?contextCategoryId=40944&amp;ref=25">

    <title>Plastic Prefilled Syringes: A Better Fit for Autoinjector Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?contextCategoryId=40944&amp;ref=25</link>

    <description>The authors describe the ways in which plastic prefilled syringes can be an alternative that provides
    consistent performance, protects drugs prone to degradation, and enhances patient safety.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757/pt-1109-sup-fig-1-p7B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?contextCategoryId=40944&amp;ref=25">

    <title>Regulatory challenges of inhaler testing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?contextCategoryId=40944&amp;ref=25</link>

    <description>Mark Copley discusses the methods used for DPI testing and the challenges presented by the current
    regulatory framework.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636406/Inhaler_web_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636406null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?contextCategoryId=40944&amp;ref=25">

    <title>Developing a modified Pulsincap system</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?contextCategoryId=40944&amp;ref=25</link>

    <description>Chronotherapeutic drug delivery systems (CRDDS) have been recognized as potentially beneficial to the
    chronotherapy (timeoptimized therapy) of widespread chronic diseases that display time-dependent
    symptoms.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638/Patel_small_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?contextCategoryId=40944&amp;ref=25">

    <title>Risk Management for Aseptic Processing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?contextCategoryId=40944&amp;ref=25</link>

    <description>The author discusses the risks involved with aseptic processing, methods and tools used to identify
    and control risk, and regulatory guidelines relevant to the risk-management process.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?contextCategoryId=40944&amp;ref=25">

    <title>From Needle to Pill: Reformulating Injectable Drugs for Oral Delivery</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?contextCategoryId=40944&amp;ref=25</link>

    <description>The author describes how Merrion Pharmaceuticals reformulates parenteral drugs into tablets and
    capsules that are easier for patients to take and provide better bioavailability.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?contextCategoryId=40944&amp;ref=25">

    <title>Case study: printing powders with Sticky Web technology</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?contextCategoryId=40944&amp;ref=25</link>

    <description>GlaxoSmithKline (GSK) appointed 42 Technology (42T) to evaluate existing powder dispensing approaches
    that could be scaled for high speed manufacturing.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637639/CaseStudy_small_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637639/CaseStudy_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?contextCategoryId=40944&amp;ref=25">

    <title>Optimizing drug delivery to the lungs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?contextCategoryId=40944&amp;ref=25</link>

    <description>An inhaler mouthpiece that optimizes drug delivery to the lungs and reduces the amount of wasted
    medication has been developed by US researchers.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637068null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40944&amp;ref=25">

    <title>Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&amp;amp;amp;D President;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business
    development, more...</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40944&amp;ref=25">

    <title>Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory Affairs;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne
    Jones senior VP and chief information officer; more...</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Reducing-Supercooling-during-the-Lyophilization-of/ArticleStandard/Article/detail/634666?contextCategoryId=40944&amp;ref=25">

    <title>Reducing Supercooling during the Lyophilization of Biologicals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Reducing-Supercooling-during-the-Lyophilization-of/ArticleStandard/Article/detail/634666?contextCategoryId=40944&amp;ref=25</link>

    <description>The manufacturing process, which influences a drug's safety and efficacy, is particularly critical for
    drugs administered through injection, and personnel must closely supervise lyophilization to ensure product
    quality.</description>

    <dc:date>2009-10-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/634666null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40944&amp;ref=25">

    <title>Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San
    Francisco appoints VP of process science; more...</description>

    <dc:date>2009-10-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40944&amp;ref=25">

    <title>Week of Oct. 5, 2009: Merck and CSL Sign Flu Vaccine Pact; Cardinal Health Names VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech;
    Sigma-Aldrich appoints VP and board member; more...</description>

    <dc:date>2009-10-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40944&amp;ref=25">

    <title>PhRMA's Stake in Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40944&amp;ref=25</link>

    <description>The nation's healtcare system needs an overhaul, but it has to be done right.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40944&amp;ref=25">

    <title>Looking Ahead: The Pharmaceutical-Science Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40944&amp;ref=25</link>

    <description>AAPS President offers hope and solutions for the industry's challenging future.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40944&amp;ref=25">

    <title>Week of Sept. 28, 2009: J&amp;amp;amp;J and Crucell Enter Collaboration; Pfizer Elects Two Directors;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam
    Molecular Therapeutics appoints CEO; more...</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-robust-formoterol-containing-suspension/ArticleStandard/Article/detail/629832?contextCategoryId=40944&amp;ref=25">

    <title>Developing robust formoterol-containing suspension pMDIs with enhanced shelf lives</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-robust-formoterol-containing-suspension/ArticleStandard/Article/detail/629832?contextCategoryId=40944&amp;ref=25</link>

    <description>Formoterol presents formulators and manufacturers in the asthma and chronic obstructive pulmonary
    disease marketplace many challenges.</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629832/Slowey_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/629832null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40944&amp;ref=25">

    <title>Week of Sept. 21, 2009: AstraZeneca and Nektar Sign License Agreement; Eli Lilly Names President of Lilly
    USA, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO;
    more...</description>

    <dc:date>2009-09-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628576null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40944&amp;ref=25">

    <title>Week of Sept. 14, 2009: Evotec and Biogen Idec Form Pact; Marijn Dekkers Leaves Thermo Fisher Scientific for
    Bayer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn
    Group appoints CEO of US business; more...</description>

    <dc:date>2009-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626906null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Encaps-deal-to-target-colonic-drug-delivery/ArticleStandard/Article/detail/624872?contextCategoryId=40944&amp;ref=25">

    <title>Encap's deal to target colonic drug delivery</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Encaps-deal-to-target-colonic-drug-delivery/ArticleStandard/Article/detail/624872?contextCategoryId=40944&amp;ref=25</link>

    <description>Encap Drug Delivery (UK) has licensed a coating technology that targets the release of drugs to the
    colon.</description>

    <dc:date>2009-09-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624872null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Controlled-Release-Formulations-a-Popular-Strategy/ArticleStandard/Article/detail/624970?contextCategoryId=40944&amp;ref=25">

    <title>Controlled-Release Formulations a Popular Strategy for Generic-Drug Companies</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Controlled-Release-Formulations-a-Popular-Strategy/ArticleStandard/Article/detail/624970?contextCategoryId=40944&amp;ref=25</link>

    <description>Generic-drug companies are increasingly viewing the development of controlled-release formulations as
    a way of obtaining a competitive edge, according to a report published by Espicom Business Intelligence in late
    August 2009.</description>

    <dc:date>2009-09-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624970null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40944&amp;ref=25">

    <title>Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma
    appoints CEO and chairman; more...</description>

    <dc:date>2009-09-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624922null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/One-Shot-H1N1-Vaccine-Gets-Chinese-Thumbs-Up/ArticleStandard/Article/detail/623600?contextCategoryId=40944&amp;ref=25">

    <title>One-Shot H1N1 Vaccine Gets Chinese Thumbs Up</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/One-Shot-H1N1-Vaccine-Gets-Chinese-Thumbs-Up/ArticleStandard/Article/detail/623600?contextCategoryId=40944&amp;ref=25</link>

    <description>An H1N1 vaccine developed by biopharmaceutical company Sinovac Biotech (Beijing, China) has passed the
    experts evaluation organized by the Chinese State Food and Drug Administration (SFDA) and the company is expected
    to obtain a production license before the week's end.</description>

    <dc:date>2009-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623600null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40944&amp;ref=25">

    <title>Week of Aug. 31, 2009: Roche Purchases Lonza Facility; SCOLR Pharma Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...</description>

    <dc:date>2009-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623587null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40944&amp;ref=25">

    <title>Quality by Enforcement</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40944&amp;ref=25</link>

    <description>After years of promomting QbD concepts, FDA's ready to take action on nonconformers.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624202null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40944&amp;ref=25">

    <title>The Go/No-Go Mindset</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40944&amp;ref=25</link>

    <description>As new process validation guidelines emerge, industry needs to reinvent how it releases
    product.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624651null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-Incompatibility-probl/ArticleStandard/Article/detail/621300?contextCategoryId=40944&amp;ref=25">

    <title>The combination drugs debate: Incompatibility problems can be overcome</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-Incompatibility-probl/ArticleStandard/Article/detail/621300?contextCategoryId=40944&amp;ref=25</link>

    <description>Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved
    efficacy, reduced dosing, enhanced patient compliance, to name just a few.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621300/Dubey_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621300null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets-The-Effect-of-Recent/ArticleStandard/Article/detail/623097?contextCategoryId=40944&amp;ref=25">

    <title>Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and
    Applications</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets-The-Effect-of-Recent/ArticleStandard/Article/detail/623097?contextCategoryId=40944&amp;ref=25</link>

    <description>The authors describe the various available technologies used in orally disintegrating
    tablets.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097/Supp_18_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623097null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-unstable-and-unpatent/ArticleStandard/Article/detail/621293?contextCategoryId=40944&amp;ref=25">

    <title>The combination drugs debate: unstable and unpatentable</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/The-combination-drugs-debate-unstable-and-unpatent/ArticleStandard/Article/detail/621293?contextCategoryId=40944&amp;ref=25</link>

    <description>Combination products have been researched and administered for many years, some successfully and
    others not.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621293/Dubey_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621293null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40944&amp;ref=25">

    <title>Week of Aug. 24, 2009: Warner Chilcott Buys P&amp;amp;amp;G Pharma Business; Amylin Appoints Former Novartis
    Exec As Chairman; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40944&amp;ref=25</link>

    <description>Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory
    affairs; more...</description>

    <dc:date>2009-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621551null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Forest Labs and AstraZeneca Form Pact; Endo COO Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620144null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Researchers-Develop-First-Aptamer-Liposome-Deliver/ArticleStandard/Article/detail/620135?contextCategoryId=40944&amp;ref=25">

    <title>Researchers Develop First Aptamer-Liposome Delivery System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Researchers-Develop-First-Aptamer-Liposome-Deliver/ArticleStandard/Article/detail/620135?contextCategoryId=40944&amp;ref=25</link>

    <description>Researchers at the University of Illinois (Champaign) have developed a cancer drug delivery system
    that reportedly kills target tumor cells, spars healthy cells, and has effects that can be reversed to halt
    potentially hazardous side effects.</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620135null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40944&amp;ref=25">

    <title>Regulatory Roundup: FDA Reorganizes the Office of the Commissioner, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-Roundup-FDA-Reorganizes-the-Office-of-t/ArticleStandard/Article/detail/620139?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice;
    more...</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620139null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Nabi and GSK Form Pact; Cardinal Health Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40944&amp;ref=25</link>

    <description>Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire;
    more...</description>

    <dc:date>2009-08-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618405null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Cherokee and DuPont Form Supply Agreement; Mylan Makes Changes in Management Team;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific
    advisory board; more...</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616603null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40944&amp;ref=25">

    <title>Of Hubris and Happy Endings</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40944&amp;ref=25</link>

    <description>Individuals and companies at the top seem to have no problem short-circuiting their
    success.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615813null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40944&amp;ref=25">

    <title>For Biotherapeutics, Innovation is Not Enough</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40944&amp;ref=25</link>

    <description>Biotech firms must first close the gaps between science and biology on the path toward
    QbD.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40944&amp;ref=25">

    <title>Company, People, and Regulatory Notes: Amgen and GSK Collaborate; WuXi Appoints VP of Pharmacology;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases
    final rule on authorized generic drugs and NDA submissions; more...</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40944&amp;ref=25">

    <title>Company, People, and Regulatory Briefs: Teva and Ortho Extend Agreement; Biogen Idec Cofounder Retires;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Gilead and Tibotec form agreement; FDA approves 2009-2010 flu vaccine; Catalent appoints VP in
    packaging unit; more...</description>

    <dc:date>2009-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612961null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Topical-Dermatological-Formulation-Development-nda/ArticleStandard/Article/detail/612809?contextCategoryId=40944&amp;ref=25">

    <title>Topical Dermatological Formulation Development &amp;amp;ndash; &amp;#34;Things You Should
    Know&amp;#34;</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Topical-Dermatological-Formulation-Development-nda/ArticleStandard/Article/detail/612809?contextCategoryId=40944&amp;ref=25</link>

    <description>&amp;#34;Things You Should Know&amp;#34; will answer many of your questions and will provide insight
    into issues you may not have considered &amp;amp;mdash; but should be aware when developing a topical formulation.
    The target product profile, dosage form selection, reasons for multiple excipients, the formulation development
    process, prototype screening, and lead formulation selection are discussed.</description>

    <dc:date>2009-07-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612809null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Merck and Portola Sign Agreement; Eisai Appoints Senior Vice-Presidents; More
    ...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Lonza and Medarex sign agreement; Covance appoints VP and chief scientific officer of global
    analytical services; more...</description>

    <dc:date>2009-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/611109null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Pfizer and Graceway Form Deal; GeoVax Labs Leader Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Lundbeck acquired LifeHealth; FDA is seeking a director of its new tobacco regulation branch;
    Charles River Labs announces personnel changes; more...</description>

    <dc:date>2009-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609491null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Advances-in-the-Pharmaceutical-Sciences/ArticleStandard/Article/detail/608519?contextCategoryId=40944&amp;ref=25">

    <title>Advances in the Pharmaceutical Sciences</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Advances-in-the-Pharmaceutical-Sciences/ArticleStandard/Article/detail/608519?contextCategoryId=40944&amp;ref=25</link>

    <description>As the pharmaceutical industry turns its efforts to biologic-based drugs and to more targeted delivery
    approaches, new tools are needed. Some recent developments are discussed.</description>

    <dc:date>2009-07-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608519null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/A-Tale-of-Two-Techniques/ArticleStandard/Article/detail/607461?contextCategoryId=40944&amp;ref=25">

    <title>A Tale of Two Techniques</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/A-Tale-of-Two-Techniques/ArticleStandard/Article/detail/607461?contextCategoryId=40944&amp;ref=25</link>

    <description>Pan coating has been the preferred method of coating tablets for more than 20 years, but core coating
    is becoming more popular.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607461/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607461null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Novel-Approaches-for-Oral-Insulin-Delivery/ArticleStandard/Article/detail/609407?contextCategoryId=40944&amp;ref=25">

    <title>Novel Approaches for Oral Insulin Delivery</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Novel-Approaches-for-Oral-Insulin-Delivery/ArticleStandard/Article/detail/609407?contextCategoryId=40944&amp;ref=25</link>

    <description>The authors review various oral drug delivery systems that have been explored to increase patient
    compliance for insulin.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609407/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609407null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40944&amp;ref=25">

    <title>The Good Society</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40944&amp;ref=25</link>

    <description>Is it good policy to pay for bad behavior?</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607467null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40944&amp;ref=25">

    <title>Can Industry Learn to Share?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40944&amp;ref=25</link>

    <description>The regulators are doing it. But industry's fear of sharing information may leave them
    behind.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607463null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Down-the-Track-Different-Speeds-with-Multiple-APIs/ArticleStandard/Article/detail/607448?contextCategoryId=40944&amp;ref=25">

    <title>Down the Track: Different Speeds with Multiple APIs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Down-the-Track-Different-Speeds-with-Multiple-APIs/ArticleStandard/Article/detail/607448?contextCategoryId=40944&amp;ref=25</link>

    <description>Formulators and manufacturers have many options for modifying release profiles in multiple-API
    products.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607448/CoverStory_rotate_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: GSK and Chroma Form Development Pact; Siemen's Healthcare Appoints US CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent
    appoints VP of quality and regulatory affairs; more...</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?contextCategoryId=40944&amp;ref=25">

    <title>Avoiding Project Delays Caused by Formulation Changes</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Avoiding-Project-Delays-Caused-by-Formulation-Chan/ArticleStandard/Article/detail/607230?contextCategoryId=40944&amp;ref=25</link>

    <description>For pharmaceutical manufacturing companies, every decision in the product development process can
    impact the project outcome. By working closely with a reliable Contract Research Organization, clients can take the
    necessary precautions to avoid risks throughout the development program. A new white paper from SP Formulations,
    titled &amp;#34;Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes&amp;#34;, presents some of
    the problems associated with 'simple' formulation changes. In addition to providing guidance on outsourcing drug
    development needs, the white paper presents a case study detailing the alternative approaches available for
    formulating a lyophilized product.</description>

    <dc:date>2009-06-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607230null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Synta and GSK End Agreement; WuXi Appoints US VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps
    down; more...</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Dr. Reddy and GSK Form Pact; Hollis-Eden Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI
    makes changes to its India management team; more...</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: CSL and Talecris Terminate Merger Agreement; Eli Lilly Hires Former Indianapolis
    Mayor; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to
    examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: AstraZeneca and Merck Collaborate on Cancer Drug; Catalent Appoints Senior VP;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, WACKER expands Iowa facility; EMEA releases a Q&amp;amp;amp;A document for PIPs; Metrics
    consolidates quality operations; more...</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?contextCategoryId=40944&amp;ref=25">

    <title>Pharmacosomes: A Potential Alternative to Conventional Vesicular Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Pharmacosomes-A-Potential-Alternative-to-Conventio/ArticleStandard/Article/detail/601891?contextCategoryId=40944&amp;ref=25</link>

    <description>Pharmacosomes can pass through biomembranes efficiently and possess several advantages over
    traditional vesicular drug-delivery systems.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601891null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40944&amp;ref=25">

    <title>Beneath the Surface</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40944&amp;ref=25</link>

    <description>It can take a lot of work to make sure nothing happens.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40944&amp;ref=25">

    <title>Truth and Transparency</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40944&amp;ref=25</link>

    <description>Misleading the public about their investments&amp;amp;mdash;be it money or medicine&amp;amp;mdash;is
    unacceptable.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Cobras-oral-vaccination-platform/ArticleStandard/Article/detail/597972?contextCategoryId=40944&amp;ref=25">

    <title>Cobra's oral vaccination platform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Cobras-oral-vaccination-platform/ArticleStandard/Article/detail/597972?contextCategoryId=40944&amp;ref=25</link>

    <description>Dr Rocky Cranenburgh, Head of Molecular Biology at Cobra Biomanufacturing Plc, talks about the
    company's unique oral vaccine delivery technology.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/202009/597972null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/David-Blakey-151-Accelerating-the-development-proc/ArticleStandard/Article/detail/595120?contextCategoryId=40944&amp;ref=25">

    <title>David Blakey &amp;amp;#151; Accelerating the development process for inhalers</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/David-Blakey-151-Accelerating-the-development-proc/ArticleStandard/Article/detail/595120?contextCategoryId=40944&amp;ref=25</link>

    <description>David Blakey, Head of Drug Delivery at Cambridge Consultants (UK), talks about the release of the
    company's Dry Powder Inhaler (DPI) generic specification.</description>

    <dc:date>2009-06-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/182009/595120null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Pfizer Forms Licensing Agreements; Malvinder Mohan Singh Steps Down at Ranbaxy,
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Johnson &amp;amp;amp; Johnson acquires Cougar Biotechnology; NIH launches program for rare and
    neglected diseases; PPD restructures leadership positions; more...</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/Prefilled-syringes-proving-popular/ArticleStandard/Article/detail/598148?contextCategoryId=40944&amp;ref=25">

    <title>Prefilled syringes proving popular</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/Prefilled-syringes-proving-popular/ArticleStandard/Article/detail/598148?contextCategoryId=40944&amp;ref=25</link>

    <description>Despite consumer demand for needle-free methods of drug delivery, the traditional injection remains
    the dominant paradigm, and prefilled injection devices, which are quicker and easier to use and enable premeasured
    and presterilized dosing, are being increasingly integrated into the plans of pharma and biotech
    companies.</description>

    <dc:date>2009-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/202009/598148null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Teva and Lonza Joint Venture Approved; Novartis CFO to Retire; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO;
    more...</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599148null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?contextCategoryId=40944&amp;ref=25">

    <title>Prefilled Syringes Growing More Popular</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Prefilled-Syringes-Growing-More-Popular/ArticleStandard/Article/detail/599068?contextCategoryId=40944&amp;ref=25</link>

    <description>According to a report from Greystone Associates in Amherst, New Hampshire, prefilled syringes are
    replacing vials both in terms of injections and sector revenue, and as this trend continues during the next four
    years, the number of tailored injectable drug products reaching the market is set to escalate.</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599068null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/New-drug-delivery-device-for-GSKs-iAvamysi/ArticleStandard/Article/detail/597070?contextCategoryId=40944&amp;ref=25">

    <title>New drug delivery device for GSK's Avamys</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/New-drug-delivery-device-for-GSKs-iAvamysi/ArticleStandard/Article/detail/597070?contextCategoryId=40944&amp;ref=25</link>

    <description>A division of Presspart has begun manufacturing a six-piece nasal drug delivery device for
    GlaxoSmithKline's intranasal corticosteroid treatment for allergic rhinitis.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/192009/597070null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: GSK Forms Pact with Aspen Pharmacare; Sigma-Aldrich Chairman to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president
    and CEO; more...</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Jubilant Biosys Forms Pact with AstraZeneca; Pfizer Appoints Chief Medical
    Officer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for
    botulinum toxin producs; C. Richter King joins IAVI; more...</description>

    <dc:date>2009-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597076null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/596054?contextCategoryId=40944&amp;ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/596054?contextCategoryId=40944&amp;ref=25</link>

    <description>Brief pharmaceutical news items for May 2009.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596054null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40944&amp;ref=25">

    <title>Shop Floor and Top Floor, Unite!</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40944&amp;ref=25</link>

    <description>Technology can solve enterprise-level problems.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596049null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40944&amp;ref=25">

    <title>Biotechnology in 2009</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40944&amp;ref=25</link>

    <description>The president of BIO proposes the ingredients needed for industry growth.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596053null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/drug+delivery/Narrowing-the-gap-between-clinical-capsule-formula/ArticleStandard/Article/detail/595149?contextCategoryId=40944&amp;ref=25">

    <title>Narrowing the gap between clinical capsule formulations and commercial film-coated tablets</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/drug+delivery/Narrowing-the-gap-between-clinical-capsule-formula/ArticleStandard/Article/detail/595149?contextCategoryId=40944&amp;ref=25</link>

    <description>Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable
    compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug
    development.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/182009/595149/Ngoc_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/drug+delivery/Orally-disintegrating-tablets-the-path-to-improved/ArticleStandard/Article/detail/595066?contextCategoryId=40944&amp;ref=25">

    <title>Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle
    management</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/drug+delivery/Orally-disintegrating-tablets-the-path-to-improved/ArticleStandard/Article/detail/595066?contextCategoryId=40944&amp;ref=25</link>

    <description>Orally disintegrating tablets offer numerous advantages compared with traditional tablets and
    capsules, and can be an effective solution for developing line extensions of currently marketed
    therapies.</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/172009/595066/Pillai_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: CIGNA and Merck Agree on Drug Pricing Plan; Kathleen Sebelius Confirmed as head of
    HHS; More</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP;
    more...</description>

    <dc:date>2009-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/595723null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/Inhaler-helps-influenza-clinical-trial/ArticleStandard/Article/detail/593885?contextCategoryId=40944&amp;ref=25">

    <title>Inhaler helps influenza clinical trial</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/Inhaler-helps-influenza-clinical-trial/ArticleStandard/Article/detail/593885?contextCategoryId=40944&amp;ref=25</link>

    <description>Daiichi Sankyo (Japan) is using Hovione?s (Portugal) TwinCaps dry powder inhaler device for its
    inhaled, long-acting neuraminidase inhibitor active against the influenza virus.</description>

    <dc:date>2009-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/162009/593885null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: GSK Acquires Stiefel Laboratories; Roche Announces Changes at Genentech;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40944&amp;ref=25</link>

    <description>Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin
    manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...</description>

    <dc:date>2009-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/172009/594648null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: DSM and Shire Form Pact; Pfizer Names Oncology Unit Exec; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board;
    more...</description>

    <dc:date>2009-04-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/162009/593691null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: BMS and Otsuka Extend Abilify Agreement; Takeda Reorganizes Corporate Structure;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-BMS-and-Otsuka-Extend-Abi/ArticleStandard/Article/detail/592425?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular
    appointed Robert Radie president and CEO</description>

    <dc:date>2009-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/152009/592425null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40944&amp;ref=25">

    <title>Parallel Tracks</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Parallel-Tracks/ArticleStandard/Article/detail/590455?contextCategoryId=40944&amp;ref=25</link>

    <description>Obama's cost-containment and science-innovation initiatives need to overlap.</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40944&amp;ref=25">

    <title>Moving Toward a Drug Development Boon or Bust?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/PharmTech+Talk/Moving-Toward-a-Drug-Development-Boon-or-Bust/ArticleStandard/Article/detail/590456?contextCategoryId=40944&amp;ref=25</link>

    <description>The financial and economic downturn is likey to have long-term implications for
    outsourcing.</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590456null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: EMD Serono to Open Cambridge, MA, site; Akorn Appoints Interim CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-EMD-Serono-to-Open-Cambri/ArticleStandard/Article/detail/590969?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, SOCMA changes name; two FDA approvals; Biogen Idec names chief operating officer;
    more...</description>

    <dc:date>2009-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590969null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Feature+Articles/Influence-of-Superdisintegrants-on-the-Rate-of-Dru/ArticleStandard/Article/detail/590450?contextCategoryId=40944&amp;ref=25">

    <title>Influence of Superdisintegrants on the Rate of Drug Dissolution from Oral Solid Dosage Forms</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Feature+Articles/Influence-of-Superdisintegrants-on-the-Rate-of-Dru/ArticleStandard/Article/detail/590450?contextCategoryId=40944&amp;ref=25</link>

    <description>The authors examine common superdisintegrants (i.e., crospovidone Type A, crospovidone Type B,
    croscarmellose sodium, and sodium starch glycolate) with a set of poorly soluble drug actives and evaluate in vitro
    drug dissolution.</description>

    <dc:date>2009-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/142009/590450/BalaImage_web_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Daiichi Sankyo Sues 13 Generic Drugmakers; Ischemix Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Daiichi-Sankyo-Sues-13-Ge/ArticleStandard/Article/detail/589404?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Hospira to reduce workforce; WuXi AppTech makes senior appointments; more...</description>

    <dc:date>2009-03-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/132009/589404null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/A-smoother-alternative-to-needles/ArticleStandard/Article/detail/588581?contextCategoryId=40944&amp;ref=25">

    <title>A smoother alternative to needles?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/A-smoother-alternative-to-needles/ArticleStandard/Article/detail/588581?contextCategoryId=40944&amp;ref=25</link>

    <description>The use of needles for vaccinations could one day be replaced by a more delicious (and less prickly)
    alternative &amp;amp;#151; yoghurt smoothies.</description>

    <dc:date>2009-03-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/132009/588581null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Gilead Sciences to Acquire CV Therapeutics; DOR Biopharma Appoints Chief Medical
    Officer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Gilead-Sciences-to-Acquir/ArticleStandard/Article/detail/587538?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Genzyme receives warning letter; Mesa Laboratories appoints John J. Sullivan CEO and a member of
    the board of directors; more...</description>

    <dc:date>2009-03-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/122009/587538null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: MannKind to Purchase Pfizer Facility; Catalent Appoints President and CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-MannKind-to-Purchase-Pfiz/ArticleStandard/Article/detail/586726?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Penn Pharma to expand; stem cell research funding ban lifted; Bristol-Myers Squibb made senior
    appointments; more...</description>

    <dc:date>2009-03-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/112009/586726null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Elan Announces Restructuring; Von Eschenbach Joins Greenleaf Health;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Elan-Announces-Restructur/ArticleStandard/Article/detail/584824?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Schering-Plough's vaccine unit, Nobilon, formed an agreement with the World Health Organization;
    Ore Pharmaceuticals named president and CEO; more...</description>

    <dc:date>2009-03-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584824null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40944&amp;ref=25">

    <title>API Outsourcing is Mixed</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/API-Outsourcing-is-Mixed/ArticleStandard/Article/detail/584962?contextCategoryId=40944&amp;ref=25</link>

    <description>Contract manufacturers of APIs and intermediates report gains, but express caution.</description>

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584962null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40944&amp;ref=25">

    <title>Critical Challenges Require Core Values</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Critical-Challenges-Require-Core-Values/ArticleStandard/Article/detail/584960?contextCategoryId=40944&amp;ref=25</link>

    <description>Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process
    to keep pharma moving forward.</description>

    <dc:date>2009-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/102009/584960null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: Genentech Tells Shareholders to Reject Roche's Tender Offer; Cryoport Appoints
    President and CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Genentech-Tells-Sharehold/ArticleStandard/Article/detail/583427?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, GPC Biotech AG and Agennix to merge; BASi appoints COO of scientific services;
    more...</description>

    <dc:date>2009-02-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/092009/583427null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Latest+News/Patent-secures-new-drug-delivery-method/ArticleStandard/Article/detail/582537?contextCategoryId=40944&amp;ref=25">

    <title>Patent secures new drug delivery method</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Latest+News/Patent-secures-new-drug-delivery-method/ArticleStandard/Article/detail/582537?contextCategoryId=40944&amp;ref=25</link>

    <description>Novozymes Biopharma and Upperton Ltd (UK) are celebrating the granting of a European patent for their
    targeted drug delivery method that makes it possible to deliver large quantities of drugs and other agents to
    selected sites in the body.</description>

    <dc:date>2009-02-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtecheurope/082009/582537null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: KV Pharmaceutical Restructures; Otsuka America Appoints Mark Altmeyer President
    and CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-KV-Pharmaceutical-Restruc/ArticleStandard/Article/detail/582512?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, Sandoz received approval for its third biosimilar from the EU, WuXi PharmaTech's CFO Benson
    Tsang to leave at month's end; more...</description>

    <dc:date>2009-02-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/082009/582512null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: King Announces Restructuring; SCOLR Pharma Appoints President and CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-King-Announces-Restructur/ArticleStandard/Article/detail/580965?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, PPD to acquire AbC.R.O.; Bilcare Global Clinical Supplies named Tony Moult general manager of
    Bilcare GCS Europe; more...</description>

    <dc:date>2009-02-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/072009/580965null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40944&amp;ref=25">

    <title>Company and People Notes: AstraZeneca Announces More Job Cuts; Deirdre Connelly Leaves Eli Lilly for GSK;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-Announces-Mor/ArticleStandard/Article/detail/579768?contextCategoryId=40944&amp;ref=25</link>

    <description>Also, recalls for two KV Pharmaceutical subsidiaries; Human Genome Sciences delivers anthrax drug to
    US Strategic National Stockpile; Akorn president and CEO leaves the company; more...</description>

    <dc:date>2009-02-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/579768null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40944&amp;ref=25">

    <title>Pharma Forecast</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Pharma-Forecast/ArticleStandard/Article/detail/580024?contextCategoryId=40944&amp;ref=25</link>

    <description>A recent reader poll focused on predictions for the industry's future.</description>

    <dc:date>2009-02-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062009/580024null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


